Jennison Associates
EDIT icon

Jennison Associates’s Editas Medicine EDIT Stock Holding History

Jennison Associates’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-237,745
Closed -$811K – 600
2024
Q3 		$811K Buy
237,745
+112,857
+90% +$491K ﹤0.01% 505
2024
Q2 		$583K Buy
124,888
+18,368
+17% +$104K ﹤0.01% 540
2024
Q1 		$790K Buy
106,520
+24,000
+29% +$199K ﹤0.01% 517
2023
Q4 		$836K Sell
82,520
-10,280
-11% -$90.2K ﹤0.01% 510
2023
Q3 		$724K Sell
92,800
-24,981
-21% -$214K ﹤0.01% 504
2023
Q2 		$969K Buy
117,781
+21,927
+23% +$191K ﹤0.01% 486
2023
Q1 		$695K Buy
95,854
+2,977
+3% +$26.5K ﹤0.01% 536
2022
Q4 		$824K Buy
92,877
+36,483
+65% +$400K ﹤0.01% 517
2022
Q3 		$690K Sell
56,394
-7,380
-12% -$115K ﹤0.01% 551
2022
Q2 		$754K Buy
63,774
+11,061
+21% +$148K ﹤0.01% 549
2022
Q1 		$1M Buy
+52,713
New +$980K ﹤0.01% 558
2016
Q3 		– Sell
-170,940
Closed -$4.13M – 661
2016
Q2 		$4.13M Hold
170,940
– – ﹤0.01% 506
2016
Q1 		$5.7M Buy
+170,940
New +$4.49M 0.01% 486

Other funds holding EDIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jennison Associates's EDIT Position: Q4 2024 in Review

Jennison Associates sold out of Editas Medicine (EDIT) in Q4 2024, closing a stake of 237,745 shares — an estimated $811K sold.

Jennison Associates first reported a position in EDIT in Q1 2016 and held it in 13 quarters. The position peaked at $5.7M in Q1 2016. 207 funds tracked by Wall St. Rank hold EDIT as of Q4 2024.

  • Jennison Associates reported no remaining Editas Medicine position as of Q4 2024 after selling out during the quarter.
  • Jennison Associates sold 237,745 Editas Medicine shares in Q4 2024, an estimated $811K.
  • Jennison Associates first reported a position in Editas Medicine in Q1 2016 and held it in 13 quarters.
  • Jennison Associates's Editas Medicine position peaked at $5.7M in Q1 2016.
  • 207 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2024.

Based on Jennison Associates's 13F filing for Q4 2024, filed 24 Jan 2025.